Actinium Pharmaceuticals annual operating margin
2021
2022
2023
2025
Actinium Pharmaceuticals Operating Margin Growth & History (ATNM)
Actinium Pharmaceuticals's operating margin was −40,274.44% for fiscal 2025.
View full Actinium Pharmaceuticals company overviewActinium Pharmaceuticals annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −40,274.44% | +23824.32 pp |
| 2023 | 2023-12-31 | −64,098.77% | −60787.70 pp |
| 2022 | 2022-12-31 | −3,311.07% | −1128.90 pp |
| 2021 | 2021-12-31 | −2,182.17% | — |
Actinium Pharmaceuticals quarterly operating margin
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q3.25
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 78.76% | +628.12 pp |
| Q3 2025 | 2025-09-30 | −6,324.44% | +28666.86 pp |
| Q3 2022 | 2022-09-30 | −21,775.56% | −18999.16 pp |
| Q2 2022 | 2022-06-30 | −17,444.44% | −15536.55 pp |
| Q1 2022 | 2022-03-31 | −549.36% | +314.30 pp |
| Q4 2021 | 2021-12-31 | −34,991.30% | — |
| Q3 2021 | 2021-09-30 | −2,776.39% | — |
| Q2 2021 | 2021-06-30 | −1,907.89% | — |
| Q1 2021 | 2021-03-31 | −863.67% | — |
Actinium Pharmaceuticals operating margin trends
Across the available reported history, Actinium Pharmaceuticals's operating margin increased from −64,098.77% to −40,274.44%, a change of +23824.32 percentage points. The latest reported quarter, Q2 2026, shows 78.76%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Actinium Pharmaceuticals filings at SEC.gov ↗